Of note, Elovl5 expression in patients with an N0 status is already much lower in Her2+ and TNBC breast cancer tissues compared to ER+ breast cancer tissues and is closer to the downregulated Elovl5 expression in ER+ breast cancer tissues from patients with N1 status. The gene discussed is ERBB2; the disease is breast cancer.